Breast diseases

PubMed Free Full Text

Breast cancer treatment: antiestrogens

Australia, New Zealand

• Royal Australian and New Zealand College of Obstetricians and Gynaecologists
  • Tamoxifen and the endometrium [2019]

Canada

• Cancers
  • Efficacy of Fulvestrant in Women with Hormone-Resistant Metastatic Breast Cancer (mBC): A Canadian Province Experience [2021]

• Ontario Health
  • Tamoxifen
  • Fulvestrant

Europe

• Breast
  • Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective [2017]

• European Medicines Agency
  • Faslodex

High-income countries

• Cancer Reports
  • Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose-response meta-analysis [2023]

International

• Cancer Medicine
  • Fulvestrant in the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: A review [2019]

• Clinical Pharmacology & Therapeutics
  • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy [2018]

• Cochrane Database of Systematic Reviews
  • Fulvestrant for hormone-sensitive metastatic breast cancer [2017]

Republic of Korea

• Frontiers in Oncology
  • Effect of Tamoxifen on the Risk of Osteoporosis and Osteoporotic Fracture in Younger Breast Cancer Survivors: A Nationwide Study [2020]

South Africa

• Breast Cancer Research and Treatment
  • The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa [2023]

Sweden

• Breast
  • Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy [2023]

Taiwan

• PLoS ONE
  • Is tamoxifen good enough for the Asian population in ER+ HER2- post-menopausal women with early breast cancer? A nationwide population-based cohort study [2024]

United Kingdom

• National Institute for Health and Care Excellence
  • Elacestrant for treating oestrogen receptor-positive HER2-negative advanced breast cancer with an ESR1 mutation after endocrine treatment [2025]
  • Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer [2018]
  • Fulvestrant for the treatment of locally advanced or metastatic breast cancer [2011]

United States

• American College of Medical Genetics and Genomics
  • Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy [2012]

• American College of Obstetricians and Gynecologists
  • Tamoxifen and Uterine Cancer [2014]

• StatPearls
  • Tamoxifen

{Related topics}

• Topic
  • Breast cancer treatment